Axion is developing advanced energy storage devices that it refers to as e3 Supercells. Axion's e3 Supercells replace the lead-based negative electrodes found in conventional lead-acid batteries with nanoporous carbon electrodes.
Applied X-ray Optics and High Precision Deposition - develops and applies various high precision deposition techniques for the production of nanometer single and multilayers showing sub-nanometer precision.
The company was founded for the purpose of research and development of new therapies for the treatment of specific and hitherto incurable forms of leukaemia. Its business is the production, research and development of targeted pharmaceuticals based on nanoparticle structures.
A specialty pharmaceutical company with a novel drug delivery system. Its proprietary Protein Stabilized Liposomes nanotechnology platform addresses the significant problems associated with delivery of water insoluble drugs.